Bailard »

Pmv Pharmaceuticals shares owned by Bailard

Quarter-by-quarter ownership of Pmv Pharmaceuticals (PMVP) shares owned by Bailard from 13F filings

Historical chart of Bailard investment in Pmv Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pmv Pharmaceuticals held by Bailard consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pmv Pharmaceuticals by Bailard

Quarter filed Position value Share count Share price at filing
2025-12-31 $21k 17k 1.25

More positions owned by Bailard

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Msci Eafe Etf (EFA)
Gilead Sciences (GILD)
Vanguard World Inf Tech Etf (VGT)
Ishares Tr Calif Mun Bd Etf (CMF)
J P Morgan Exchange Traded F Mortgage Backed (JMTG)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Ibonds 26 Trm Ts (IBTG)

View all positions for Bailard

Top funds holding Pmv Pharmaceuticals

BML Capital Management
OrbiMed Advisors
Tang Capital Management
Arrowpoint Asset Management
Sio Capital Management
Euclidean Capital
Vanguard Group
Acadian Asset Management
Stonepine Capital Management
BlackRock
Jacobs Levy Equity Management
Jane Street
Aldebaran Capital
Marshall Wace
Geode Capital Management

View all funds holding Pmv Pharmaceuticals